NeuroSearch AS (NEUR):企業の財務・戦略的SWOT分析

GlobalDataが発行した調査報告書(DATA904C12050)
◆英語タイトル:NeuroSearch AS (NEUR) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C12050
◆発行会社(リサーチ会社):GlobalData
◆発行日:2018年12月
◆ページ数:42
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:デンマーク
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

NeuroSearch AS (NEUR) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

NeuroSearch AS (NeuroSearch) focuses on the development of novel pharmaceutical agents for the treatment of various disorders of central nervous system (CNS) through license agreements with other life science companies. The company divested all rights of Huntexil for the treatment of patients with Huntington’s disease to Teva Pharmaceuticals. It also sold all the preclinical and clinical assets, and further development of NS2330 (tesofensine) and NS2359 as well as of any potential drugs based on NS2330 or NS2359 to Saniona A/S and Saniona AB (Saniona). NeuroSearch is entitled to receive a one-time cash payment from Saniona and milestone payments from Teva. NeuroSearch is headquartered in Hallerup, Denmark.

NeuroSearch AS Key Recent Developments

Aug 30,2018: NeuroSearch – H1 report 2018
Dec 05,2017: Update on NeuroSearch’s business status and future
Aug 31,2017: NeuroSearch – H1 report 2017
Feb 24,2017: NeuroSearch releasing Annual Report 2016

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
NeuroSearch AS – Key Facts 5
NeuroSearch AS – Key Employees 6
NeuroSearch AS – Key Employee Biographies 7
NeuroSearch AS – Major Products and Services 8
NeuroSearch AS – History 9
NeuroSearch AS – Company Statement 13
NeuroSearch AS – Locations And Subsidiaries 14
Head Office 14
Other Locations & Subsidiaries 14
Section 2 – Company Analysis 15
Company Overview 15
NeuroSearch AS – Business Description 16
NeuroSearch AS – SWOT Analysis 17
SWOT Analysis – Overview 17
NeuroSearch AS – Strengths 17
NeuroSearch AS – Weaknesses 18
NeuroSearch AS – Opportunities 19
NeuroSearch AS – Threats 20
NeuroSearch AS – Key Competitors 21
Section 3 – Company Financial Ratios 22
Financial Ratios – Capital Market Ratios 22
Financial Ratios – Annual Ratios 23
Performance Chart 25
Financial Performance 25
Financial Ratios – Interim Ratios 26
Financial Ratios – Ratio Charts 27
Section 4 – Company’s Lifesciences Financial Deals and Alliances 28
NeuroSearch AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28
NeuroSearch AS, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 29
NeuroSearch AS, Recent Deals Summary 30
Section 5 – Company’s Recent Developments 31
Aug 30, 2018: NeuroSearch – H1 report 2018 31
Dec 05, 2017: Update on NeuroSearch’s business status and future 33
Aug 31, 2017: NeuroSearch – H1 report 2017 34
Feb 24, 2017: NeuroSearch releasing Annual Report 2016 36
Section 6 – Appendix 38
Methodology 38
Ratio Definitions 38
About GlobalData 42
Contact Us 42
Disclaimer 42

List of Tables
NeuroSearch AS, Key Facts 5
NeuroSearch AS, Key Employees 6
NeuroSearch AS, Key Employee Biographies 7
NeuroSearch AS, Major Products and Services 8
NeuroSearch AS, History 9
NeuroSearch AS, Subsidiaries 14
NeuroSearch AS, Key Competitors 21
NeuroSearch AS, Ratios based on current share price 22
NeuroSearch AS, Annual Ratios 23
NeuroSearch AS, Annual Ratios (Cont...1) 24
NeuroSearch AS, Interim Ratios 26
NeuroSearch AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28
NeuroSearch AS, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 29
NeuroSearch AS, Recent Deals Summary 30
Currency Codes 38
Capital Market Ratios 38
Equity Ratios 39
Profitability Ratios 39
Cost Ratios 40
Liquidity Ratios 40
Leverage Ratios 41
Efficiency Ratios 41

List of Figures
NeuroSearch AS, Performance Chart (2013 - 2017) 25
NeuroSearch AS, Ratio Charts 27
NeuroSearch AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28
NeuroSearch AS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 29

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ NeuroSearch AS (NEUR):企業の財務・戦略的SWOT分析(NeuroSearch AS (NEUR) - Financial and Strategic SWOT Analysis Review)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆